KR900003154A - 우울증 치료제인 n-치환된 니코틴아미드 화합물 - Google Patents

우울증 치료제인 n-치환된 니코틴아미드 화합물 Download PDF

Info

Publication number
KR900003154A
KR900003154A KR1019890012412A KR890012412A KR900003154A KR 900003154 A KR900003154 A KR 900003154A KR 1019890012412 A KR1019890012412 A KR 1019890012412A KR 890012412 A KR890012412 A KR 890012412A KR 900003154 A KR900003154 A KR 900003154A
Authority
KR
South Korea
Prior art keywords
fluoro
chloro
benzyl
compound
hydrogen
Prior art date
Application number
KR1019890012412A
Other languages
English (en)
Other versions
KR920000760B1 (ko
Inventor
알렉스 사코마노 니콜라스
제임스 비닉 프레드릭
Original Assignee
윌리암 데이비스 헌
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 데이비스 헌, 화이자 인코포레이티드 filed Critical 윌리암 데이비스 헌
Publication of KR900003154A publication Critical patent/KR900003154A/ko
Application granted granted Critical
Publication of KR920000760B1 publication Critical patent/KR920000760B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용 없음

Description

우울증 치료제인 N-치환된 니코틴아미드 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 하기 일반식의 화합물 또는 이의 약제학적 허용가능한 산 부가염.
    상기식에서, R3는 1-피페리딜, 1-(3-인돌릴)에틸(C1-4)-알킬, 페닐, 벤질, 1-(1-페닐에틸)또는 일치환된 벤질(여기에서 치환체는 클로로, 플루오로, 메틸 또는 메톡시이다)이고; R4는 바이시클로[2.2.1]헵트-2-일 또는(여기에서 Y는 수소, 플루오로 또는 클로로이고; X는 수소, 플루오로, 클로로, 메톡시, 트리플루오로메틸, 시아노, 카복시, 메틸카바모일, 디메틸카바모일 또는 카보(C1-4)알콕시이다)이며; 단 R3가 페닐, 벤질, 일치환된 벤질, 1-(1-페닐에틸) 또는 (C1-4)알킬이며, R4는 바이시클로[2.2.1]헵트-2-일이다.
  2. 제1항에 있어서, R3가 1-피페리딜 또는 1-(3-인돌릴)에틸인 화합물.
  3. 제2항에 있어서, R3가 1-(3-인돌릴)에틸이고 R4가 바이시클로[2.2.1]헵트-2-일인 화합물.
  4. 제2항에 있어서, R4가(여기에서 Y는 수소이고 X는 카보(C1-4)알콕시이다)인 화합물.
  5. 제4항에 있어서, R3가 1-피페리딜이고 R4가인 화합물.
  6. 활성치료 물질로서 사용하기 위한 하기 일반식을 갖는 화합물 또는 이의 약제학적 허용가능한 산 부가염.
    상기식에서 R1은 1-피페리딜, 1-(3-인돌릴)에틸, (C1-4)-알킬, 페닐, 벤질, 1-(1-페닐에틸)또는 일치환된 벤질(여기에서 치환체는 클로로, 플루오로, 메틸 또는 메톡시이다)이고; R2는 바이시클로[2.2.1]헵트-2-일 또는(여기에서 Y는 수소, 플루오로 또는 클로로이고; X는 수소, 플루오로, 클로로, 메톡시, 트리플루오로메틸, 시아노, 카복시, 메틸카바모일, 디메틸카바모일 또는 카보(C1-4)알콕시이다)이다.
  7. 제6항에 있어서, 우울증에 거린 사람의 우울증을 치료하기 위한 약제를 제조하기 위한 물질의 용도.
  8. 제7항에 있어서, R2가인 물질의 용도.
  9. 제8항에 있어서, R1이 벤질 또는 일치환된 벤질이고 R2가인 물질의 용도.
  10. 제9항에 있어서, R2가인 물질의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890012412A 1988-08-31 1989-08-30 우울증 치료제인 n-치환된 니코틴아미드 화합물 KR920000760B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US238,951 1988-08-31
US07/238,951 US4861891A (en) 1988-08-31 1988-08-31 Antidepressant N-substituted nicotinamide compounds
US238951 1999-01-27

Publications (2)

Publication Number Publication Date
KR900003154A true KR900003154A (ko) 1990-03-23
KR920000760B1 KR920000760B1 (ko) 1992-01-21

Family

ID=22899998

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890012412A KR920000760B1 (ko) 1988-08-31 1989-08-30 우울증 치료제인 n-치환된 니코틴아미드 화합물

Country Status (18)

Country Link
US (1) US4861891A (ko)
EP (1) EP0357316B1 (ko)
JP (1) JPH02115168A (ko)
KR (1) KR920000760B1 (ko)
AT (1) ATE88182T1 (ko)
AU (1) AU609329B2 (ko)
CA (1) CA1329605C (ko)
DE (1) DE68905979T2 (ko)
DK (1) DK426889A (ko)
FI (1) FI894066A (ko)
HU (1) HU208120B (ko)
IE (1) IE892775L (ko)
IL (1) IL91417A0 (ko)
MY (1) MY104179A (ko)
NO (1) NO893471L (ko)
NZ (1) NZ230493A (ko)
PT (1) PT91580B (ko)
ZA (1) ZA896626B (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
NZ337698A (en) * 1997-04-04 2001-07-27 Pfizer Prod Inc Nicotinamide derivatives for selective inhibition of phosphodiesterase type 4 (PDE4) and the production of tumour necrosis factor (TNF) useful for the treatment of respiratory, rheumatoid and allergic diseases
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
AU2700201A (en) * 2000-01-31 2001-08-14 Pfizer Products Inc. Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
DK1252157T3 (da) 2000-01-31 2004-10-25 Pfizer Prod Inc Pyrimidin-carboxamider anvendelige som inhibitorer af PDE4 isozymer
KR100661081B1 (ko) * 2000-06-10 2006-12-26 동화약품공업주식회사 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
US7250518B2 (en) * 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
EE200300362A (et) * 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad tiasolüül-, oksasolüül-, pürrolüül- ja imidasolüülhappeamiidi derivaadid
IL156413A0 (en) * 2001-01-31 2004-01-04 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
PL364910A1 (en) 2001-01-31 2004-12-27 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
GB0317472D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Nicotinamide derivatives useful as PDE4 inhibitors
JP2008503446A (ja) * 2004-05-06 2008-02-07 プレキシコン，インコーポレーテッド Ｐｄｅ４ｂ阻害剤及びその使用
CA2583428A1 (en) * 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl pde4b inhibitors
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
DK1951663T3 (en) * 2005-11-24 2016-10-10 Dompé Farm S P A (r)-arylkylaminoderivater og farmaceutiske sammensætninger indeholdende dem
WO2007098352A2 (en) * 2006-02-16 2007-08-30 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
DE102007057089B4 (de) * 2006-12-22 2010-04-29 Lg Display Co., Ltd. Flüssigkristallanzeige mit Photosensor und Herstellungsverfahren derselben
WO2008112164A2 (en) 2007-03-08 2008-09-18 The Board Of Trustees Of The Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
JP2012502048A (ja) 2008-09-08 2012-01-26 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
KR20110082180A (ko) 2008-10-28 2011-07-18 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 알데히드 탈수소효소의 조절자 및 그것의 사용방법
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251263A (en) * 1979-09-04 1981-02-17 Stauffer Chemical Company N-substituted, 2-phenoxynicotinamide compounds and the herbicidal use thereof
US4270946A (en) * 1979-10-01 1981-06-02 Stauffer Chemical Company N-Aryl,2-phenoxy nicotinamide compounds and the herbicidal use thereof
IL64220A (en) * 1980-11-21 1985-06-30 May & Baker Ltd Nicotinamide derivatives,their preparation and their use as herbicides
US4692185A (en) * 1986-01-13 1987-09-08 Stauffer Chemical Company N-(ortho-substituted) benzyl, 3-trifluoromethylphenoxy nicotinamides as herbicides

Also Published As

Publication number Publication date
AU609329B2 (en) 1991-04-26
NZ230493A (en) 1991-03-26
DE68905979T2 (de) 1993-07-22
DK426889A (da) 1990-03-01
ATE88182T1 (de) 1993-04-15
NO893471D0 (no) 1989-08-30
EP0357316B1 (en) 1993-04-14
HU208120B (en) 1993-08-30
FI894066A0 (fi) 1989-08-30
AU4091389A (en) 1990-06-28
NO893471L (no) 1990-03-01
KR920000760B1 (ko) 1992-01-21
DK426889D0 (da) 1989-08-30
MY104179A (en) 1994-02-28
JPH02115168A (ja) 1990-04-27
PT91580B (pt) 1995-05-04
EP0357316A1 (en) 1990-03-07
CA1329605C (en) 1994-05-17
ZA896626B (en) 1991-04-24
PT91580A (pt) 1990-03-08
IE892775L (en) 1990-02-28
HUT52058A (en) 1990-06-28
DE68905979D1 (de) 1993-05-19
US4861891A (en) 1989-08-29
IL91417A0 (en) 1990-04-29
FI894066A (fi) 1990-03-01

Similar Documents

Publication Publication Date Title
KR900003154A (ko) 우울증 치료제인 n-치환된 니코틴아미드 화합물
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
DE69021472D1 (de) Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung.
ATE60761T1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR900018073A (ko) 피페라진 화합물
ATE116303T1 (de) Aryl-heteroaryl-karbinol-derivate mit analgetischer aktivität.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
KR900014388A (ko) 에세롤린의 카보네이트 유도체, 이의 제조방법 및 약제로서의 용도
HUP0101469A2 (hu) 5-[(2-Imidazolidinilidén)-amino]-benzimidazol-származékok, előállításuk és alkalmazásuk javított metabolikus stabilitású alfa-adrenoceptor agonistákként
ATE28862T1 (de) Aktive kompositionen gegen motten, weisse fliegen und holzwuermer, pharmazeutische kompositionen und benzoylharnstoffderivaten.
ES8601850A1 (es) Un procedimiento para preparar derivados de ciclobutano
KR910011807A (ko) 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
HUP9802348A2 (hu) 2-Fenil-3-aroil-benzotiofének alkalmazása plazminogén aktivátor inhibitor-1 gátló hatású gyógyszerkészítmények előállítására
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
DE3786507T2 (de) Heterocyclische Propenamid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE56967T1 (de) Amidderivate.
DE69219219T2 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
KR940703656A (ko) 에이즈 바이러스 감염 저해용 조성물
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
MX9709833A (es) Uso de benzimidazoles para la fabricacion de un medicamento para el tratamiento de leucemia.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee